“…Understanding its molecular mechanism(s) of action is, however, a conditio sine qua non for considering potential beneficial and unwanted side effects. The initially suggested estrogenic activity of lipophilic components, such as triterpenoids, was disproved by later studies (Gaube et al, 2007;Mercado-Feliciano et al, 2012;Hajirahimkhan et al, 2013). There, however, is evidence that A. racemosa L. preparations interact with distinct neurotransmitter systems in the central nervous system, including m-opioid receptors (Rhyu et al, 2006;Reame et al, 2008), serotonin (5-HT) receptors (subtypes 5-HT 1A , 5-HT 1D , and 5-HT 7 ) (Burdette et al, 2003), and dopamine subtype 2 receptors (Jarry et al, 2003).…”